AVITA Medical (RCEL) EBT (2018 - 2025)
AVITA Medical (RCEL) posted EBT of -$11.6 million for Q4 2025, up 11.65% on a QoQ basis from -$13.2 million in Q3 2025, and down 0.7% year-over-year from -$11.7 million in Q4 2024.
AVITA Medical (RCEL) EBT (2018 - 2025) Analysis & Trends
AVITA Medical's EBT history runs 8 years deep, the most recent figure standing at -$11.6 million for Q4 2025.
- Quarterly EBT fell 0.7% year-over-year to -$11.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$48.6 million (up 21.37% YoY) and the FY2025 annual result came in at -$48.6 million, up 21.37% from the prior year.
- EBT was -$11.6 million for Q4 2025 at AVITA Medical, up from -$13.2 million in the prior quarter.
- Across five years, EBT topped out at $21.4 million in Q4 2022 and bottomed at -$18.6 million in Q1 2024.
- A 5-year average of -$9.6 million and a median of -$10.5 million in 2021 frame the typical range for EBT.
- Annual changes were most pronounced in 2022 — EBT surged 66.44% — and 2023, when it plunged 132.9%.
- AVITA Medical's EBT stood at -$16.6 million in 2021, then soared by 228.82% to $21.4 million in 2022, then slumped by 132.9% to -$7.1 million in 2023, then sank by 63.86% to -$11.6 million in 2024, then dropped by 0.7% to -$11.6 million in 2025.
- Business Quant data shows RCEL's EBT at -$11.6 million in Q4 2025, -$13.2 million in Q3 2025, and -$9.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.45 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 850.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.83 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.16 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 459.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 269.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 222.44 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 505.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | AVITA Medical | 140.94 Mn | 124.59 Mn | 14.31 Mn | -11.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.64 Mn |
| Sep 30, 2025 | -13.17 Mn |
| Jun 30, 2025 | -9.92 Mn |
| Mar 31, 2025 | -13.85 Mn |
| Dec 31, 2024 | -11.56 Mn |
| Sep 30, 2024 | -16.23 Mn |
| Jun 30, 2024 | -15.36 Mn |
| Mar 31, 2024 | -18.63 Mn |
| Dec 31, 2023 | -7.05 Mn |
| Sep 30, 2023 | -8.70 Mn |
| Jun 30, 2023 | -10.37 Mn |
| Mar 31, 2023 | -9.19 Mn |
| Dec 31, 2022 | 21.44 Mn |
| Sep 30, 2022 | -5.58 Mn |
| Mar 31, 2022 | -9.46 Mn |
| Sep 30, 2021 | -16.64 Mn |
| Jun 30, 2021 | -10.70 Mn |
| Mar 31, 2021 | -5.99 Mn |
| Dec 31, 2020 | -5.63 Mn |
| Sep 30, 2020 | -10.22 Mn |